Please use this identifier to cite or link to this item: http://hdl.handle.net/10311/2084
Full metadata record
DC FieldValueLanguage
dc.contributor.authorTiroyakgosi, Celda-
dc.contributor.authorMatome, Matshediso-
dc.contributor.authorKgatlwane, Joyce-
dc.contributor.authorParamadhas, Bene D Anand-
dc.contributor.authorMalone, Brighid-
dc.contributor.authorMpinda-Joseph, Pinkie-
dc.contributor.authorRwegerera, Godfrey Mutashambara-
dc.contributor.authorMaika, Keamogetse-
dc.contributor.authorMashalla, Yohana-
dc.contributor.authorGodman, Brian-
dc.contributor.authorMaselle, Amos-
dc.date.accessioned2021-03-26T14:51:48Z-
dc.date.available2021-03-26T14:51:48Z-
dc.date.issued2019-09-23-
dc.identifier.citationTiroyakgosi, C. et al. (2019) Antimicrobial utilization research and activities in Botswana, the past, present and the future. Expert Review of Anti-infective Therapy, Vol. 17, No. 10, pp. 759-762en_US
dc.identifier.issn1478-7210-
dc.identifier.urihttp://hdl.handle.net/10311/2084-
dc.description.abstractA number of activities are ongoing to reduce AMR in Botswana by improving antimicrobial utilization across all sectors. However, there is a need to share experiences. With the objective of sharing these, the second one day symposium was held in the University of Botswana in October 2018 involving both private and public hospitals. In Lenmed Bokamoso hospital, ESKAPE organisms were associated with 50- 90% of clinical infections; however, there was no correlation between healthcare associated infections (HAIs) and admission swab positivity with ESKAPE or ESBL isolates. Hang times, the time between a prescription and IV administration, were also discussed. At Nyangabwe Hospital, the prevalence of HAIs was 13.54%, 48.9% were laboratory confirmed of which 8.5% were blood stream infections (BSIs). The prevalence of different bacteria causing neonatal BSIs was also investigated. At Princess Marina Hospital, positive cultures were seen in 22.4% of blood cultures with contaminants comprising the majority. Several activities are ongoing in Botswana across sectors as a result of the findings and will be periodically reported to further improve antibiotic utilization.en_US
dc.language.isoenen_US
dc.publisherTaylor & Francis, www.tandfonline.comen_US
dc.subjectAntimicrobialsen_US
dc.subjectBlood stream infectionsen_US
dc.subjectHang timesen_US
dc.subjectHAIsen_US
dc.subjectBotswanaen_US
dc.titleAntimicrobial utilization research and activities in Botswana, the past, present and the futureen_US
dc.typePublished Articleen_US
dc.linkhttps://www.tandfonline.com/doi/pdf/10.1080/14787210.2019.1668777?needAccess=trueen_US
Appears in Collections:Research articles (Dept of Internal Medicine)

Files in This Item:
File Description SizeFormat 
Antimicrobial utilization research and activities in Botswana the past present and the future.pdfMain article760.77 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.